How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A MonthInvestors Business Daily • 02/08/24
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceGlobeNewsWire • 02/06/24
Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant ProgramGlobeNewsWire • 01/29/24
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of AficamtenGlobeNewsWire • 01/25/24
Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)Seeking Alpha • 01/12/24
Cytokinetics Rockets 14% As Novartis Reportedly Nears A Buyout DealInvestors Business Daily • 01/08/24
Cytokinetics Stock Skyrockets on Positive Results from Study of Its Heart DrugInvestopedia • 12/27/23
Cytokinetics stock rockets toward a 19-year high after positive trial data on heart disease treatmentMarket Watch • 12/27/23